We are live on ! Find out more
TSVT

2seventy bio

Delisted

TSVT was delisted on the 13th of May, 2025.

116 hedge funds and large institutions have $135M invested in 2seventy bio in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 26 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

418% more call options, than puts

Call options by funds: $57K | Put options by funds: $11K

31% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 26

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

1% more funds holding

Funds holding: 115116 (+1)

36% less capital invested

Capital invested by funds: $213M → $135M (-$77.6M)

Holders
116
Holders Change
+1
Holders Change %
+0.87%
% of All Funds
1.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
22
Increased
34
Reduced
26
Closed
18
Calls
$57K
Puts
$11K
Net Calls
+$46K
Net Calls Change
-$600K

TSVT Hedge Fund Activity: Q4 2024 in Review

116 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q4 2024, worth a combined $135M — down 36% from $213M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new TSVT positions and 18 closed out — a net gain of 4 holders — while 34 added to existing stakes and 26 trimmed.

The largest buyer was Bank of America, adding an estimated $7.85M. The largest seller was Madison Avenue Partners, cutting an estimated $8.14M.

  • 116 institutional investors held 2seventy bio (TSVT) as of Q4 2024, up from 115 in Q3 2024.
  • Funds reported $135M of 2seventy bio stock for Q4 2024, down 36% quarter-over-quarter.
  • 22 funds opened new 2seventy bio positions in Q4 2024 and 18 closed out, a net change of +4 holders.
  • The largest 2seventy bio buyer in Q4 2024 was Bank of America, an estimated $7.85M added.
  • The largest 2seventy bio seller in Q4 2024 was Madison Avenue Partners, an estimated $8.14M sold.

Based on aggregated 13F filings for Q4 2024.